219
Views
32
CrossRef citations to date
0
Altmetric
Diagnostic Profile

APTIMA®Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens

&
Pages 679-688 | Published online: 09 Jan 2014

References

  • World Health Organization (WHO). Global prevalence and incidence of selected surable sexually transmitted infections: overview and estimates. WHO, Geneva, Switzerland (2001).
  • American College of Obstetricians and Gynecologists, (ACOG). ACOG practice bulletin no. 72: vaginitis. Obstet. Gynecol.107, 1195–1206 (2006).
  • Miller W, Swygard H, Hobbs MM et al. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis.32(10), 593–598 (2005).
  • Freeman AH, Katz KA, Pandori MW et al. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex. Transm. Dis.37(3), 165–168 (2010).
  • Sutcliffe S, Newman SB, Hardick A, Gaydos C. Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates. Sex. Transm. Dis.37(9), 585–590 (2010).
  • Piperaki E-T, Theodora M, Mendris M et al. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study. J. Clin. Pathol.63(3), 249–253 (2010).
  • Krashin JW, Koumans EH, Bradshaw-Sydnor AC et al.Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex. Transm. Dis.37(7), 440–444 (2009).
  • Gaydos C, Hsieh Y-H, Barnes M et al.Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex. Transm. Dis. (2011) (In press).
  • Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz LE. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin. Infect. Dis.45(10), 1319–1326 (2007).
  • Schwebke J, Hobbs M, Taylor S et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective US clinical trial. J Clin. Microbiol. (In press) (2011).
  • Hobbs MM, Lapple DM, Lawing LF et al. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J. Clin. Pathol.44(11), 3994–3999 (2006).
  • Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mountmicroscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet Gynecol.200(2), 188.e1–188.e7 (2009).
  • Weberman B, Rosenberg SK. Evaluation of Gen-Probe Trichomonas vaginalis analyte specific reagent in urine specimens collected from male and female clients in a public health sexually transmitted disease clinic. Presented at: American Society of Microbiology 110th Annual Meeting. San Diego, CA, USA, 23–27 May 2010 (Abstract: 10-GM-A-2639-ASM).
  • Joyner J, Douglas JJ, Ragsdale S, Foster M, Judson F. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex. Transm. Dis.27(4), 236–240 (2000).
  • Andrea SB, Chapin KC. Comparison of APTIMA®Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of Trichomonas vaginalis in symptomatic women: performance parameters and epidemiologic implications. J. Clin. Microbiol.49(3), 866–869 (2011).
  • Anderson MR, Karasz A. How do clinicians manage vaginal complaints? An internet survey. MedGenMed.7(2), 61 (2005).
  • Schwiertz A, Taras D, Rusch K, Rusch V. Throwing the dice for the diagnosis of vaginal complaints? Ann. Clin. Microbiol. Antimicrob.5, 4 (2006).
  • Cevahir N, Kaleli I, Kaleli B. Evaluation of direct microscopic examination, acridine orange staining and culture methods for studies of Trichomonas vaginalis in vaginal discharge specimens. Mikrobiyol. Bul.36(3–4), 329–335 (2002).
  • Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR59(RR-12), 58–61 (2010).
  • Stark JR, Judson G, Alderete JF et al. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: physicians’ health study. J. Natl Cancer Inst.101, 1–6 (2009).
  • Francis SC, Kent CK, Klausner JD et al. Prevalence of rectal Trichomonas vaginalis and mycoplasma genitalium in male patients at the San Francisco STD clinic. 2005–2006. Sex. Transm. Dis.35(9), 797–800 (2006).
  • Gardner WJ, Culberson D, Bennett B. Trichomonas vaginalis in the prostate gland. Arch. Pathol. Lab. Med.110(5), 430–432 (1986).
  • Krieger J. Consider diagnosis and treatment of trichomoniasis in men. Sex. Transm. Dis.27(4), 241–242 (2000).
  • Fichorova R. Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J. Reprod. Immunol.83(1–2), 185–189 (2009).
  • Chesson H, Blandford J, Gift T, Tao G, Irwin K. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect. Sex. Reprod. Health36(1), 11–19 (2004).
  • Chesson H, Blandford J, Pinkerton S. Estimates of the annual number and cost of new HIV infections among young women attributable to trichomoniasis in the United States. Sex. Transm. Dis.31(9), 547–551 (2004).
  • Fuller DD, Buckner R, Newcomer K, Brunnemer C, O’Brien D, Davis TE. Comparison of APTIMA analyte specific reagents to wet mount, culture, Affirm VPIII, and OSOM trichomonas rapid test for detection of Trichomonas vaginalis from vaginal swabs & cytyc thinprep vials. Presented at: 18th International Society for Sexually Transmitted Diseases Research. London, UK, 28 June–1 July 2009 (Poster P-151).
  • Huppert J, Mortensen J, Reed J et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin. Infect. Dis.45(2), 194–198 (2007).
  • Rich K, Huppert J, Mortensen J et al. Comparison of transcription-mediated amplification, rapid anitgen test, culture, and wet mount for detection of trichomonas vaginalis in female adolescents. Presented at: 18th International Society for Sexually Transmitted Diseases Research. London, UK, 28 June–1 July 2009 (Poster P-137).
  • Sitay A, Bungo J, Dickey K et al. Rapid detection of Trichomonas vaginalis from vaginal specimens by transcription-mediated amplification. Presented at: American Society for Microbiology Meeting. Washington, DC, USA 18–22 May 2003.
  • Lara-Torre E, Pinkerton J. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based papanicolaou smear. Am. J. Obstet. Gynecol.188(2), 354–356 (2003).
  • Ohlemeyer C, Hornberger L, Lynch D, Swierkosz E. Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy. J. Adolesc. Health22(3), 205–208 (1998).
  • Levi M, Torres J, Pina C, Klein R. Comparison of the InPouch TV culture system and Diamond’s modified medium for detection of Trichomonas vaginalis. J. Clin. Microbiol.35(12), 3308–3310 (1997).
  • Chapin KC, Andrea SB, Seadale ML, Roberts MB, Nijhawan AE, Clarke JG. Comparison of the APTIMA Trichomonas (ATV) analyte-specific-reagents and InPouch culture methods for dection of Trichomonas vaginalis in incarcerated women. Presented at: 110 ASM General Meeting. San Diego, CA, USA, 23–27 May 2010.
  • Getman D, Davis I P, Bankowski M et al. Comparison of transcription-mediated amplification, culture and PCR methods for detection of Trichomonas vaginalis. Presented at: Scheveningen Molecular Meeting. Scheveningen, The Netherlands, 13–14 October 2005.
  • Campbell L, Woods V, Lloyd T, Elsayed S, Church D. Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J. Clin. Microbiol.46(10), 3467–3469 (2008).
  • Huppert J, Batteiger BE, Braslins P et al. Use of immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J. Clin. Microbiol.43(2), 684–687 (2005).
  • Andrea SB, Chapin KC. Comparison of APTIMA®Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of Trichomonas vaginalis in symptomatic women: Performance parameters and epidemiologic implications. J. Clin. Microbiol.49(3), 866–869 (2011).
  • Schwebke JR. Update of trichomoniasis. Sex. Transm. Infect.78(5), 378–379 (2002).
  • Wendel K, Erbelding E, Gaydos C, Rompalo A. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex. Transm. Dis.79(2), 151–153 (2003).
  • Hardick A, Hardick J, Wood BJ, Gaydos C. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a roche lightcycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol.44(11), 4197–4199 (2006).
  • Clarke JG, Nijhawan AE, Seadale ML, Salloway R, Chapin KC. Acceptability of routine Trichomonas screening for incarcerated women. Presented at: American Public Health Association 138 Annual Meeting. Denver, CO, USA, 6–10 November 2010.
  • Chapin KC, Andrea SB, Florczyk J, Kojic E. Comparison of transcription mediated amplification (TMA) and polymerase chain reaction (PCR) methods for detection of Trichomonas vaginalis from SUN study patients. Presented at: 2010 CDC STD Prevention Conference. Atlanta, GA, USA, 8–11 March 2010.
  • Van Der Pol B, Kraft C, Williams J. Use of an adaption of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J. Clin. Microbiol.44(2), 366–373 (2006).
  • Caliendo AM, Jordan J, Green A, Ingersoll J, Diclemente RJ, Wingwood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect. Dis. Obstet. Gynecol.13(3), 145–150 (2005).
  • Chernesky MA, Jang D, Luinstra K et al. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA combo 2 assay. J. Clin. Microbiol.44(2), 400–405 (2006).
  • Munson E, Napierala M, Olson R et al. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol.46(10), 3368–3374 (2008).
  • Hollman D, Coupey S, Fox A, Herold B. Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J. Pediatr. Adolesc. Gynecol.23(5), 312–316 (2010).
  • Girardet RG, Lahoti S, Howard LA et al. Epidemiology of sexually transmitted infections in suspected child victims of sexual assault. Pediatrics124(1), 79–86 (2009).
  • Heine P, McGregor J. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol.36(1), 137–144 (1993).
  • Mann JR, McDermott S, Barnes TL, Hardin J, Bao H, Zhou L. Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol.19, 891–899 (2009).
  • Moodley P, Wikinson D, Connolly C, Moodley J, Sturm A. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis.34(4), 519–522 (2002).
  • Burstein G, Zenilman J. Nongonococcal urethritis--a new paradigm. Clin. Infect. Dis.28(1), 66–73 (1999).
  • Cotch MF, Pastorek JGI, Nugent RP et al.Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis.24(6), 353–360 (1996).
  • Zhang Z, Begg C. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol.23(4), 682–690 (1994).
  • Shew ML, Fortenberry JD, Tu W et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Arch. Pediatr. Adolesc. Med.160, 151–156 (2006).
  • Madhivanan P, Krupp K, Chandrasekaran V et al. Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India. Indian J. Med. Microbiol.26(2), 132–137 (2008).
  • Thurman A, Doncel G. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginsosis: relationship to HIV acquisition. Am. J. Reprod. Immunol.65(2), 89–98 (2011).
  • Kissinger P, Amedee A, Clark RA et al.Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Tranm. Dis.36(1), 11–16 (2009).
  • Depuydt C, Leuridan E, Van Damme P, Bogers J, Vereecken A, Donders G. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in Flanders. Gynecol. Obstet. Invest.70(4), 273–280 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.